Literature DB >> 16985980

Optimizing outcomes of oral therapy for patients with erectile dysfunction.

James H Barada.   

Abstract

The evaluation and treatment of erectile dysfunction (ED) differs from that of many medical conditions. An intimate dialogue between the patient and physician must be established for accurate assessment of ED severity and successful therapy. Patient and partner education on the nuances of oral phosphodiesterase inhibitor therapy is important to maximize treatment success with this currently first-line therapy. Realistic expectations for the erectile response and patience are necessary to resume satisfactory sexual functioning. Relationship issues or partner resistance can contribute to a suboptimal erectile response to therapy, in which case the patient may benefit from sexual therapy referral.

Entities:  

Year:  2003        PMID: 16985980      PMCID: PMC1502380     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  14 in total

1.  Standards for privacy of individually identifiable health information. Office of the Assistant Secretary for Planning and Evaluation, DHHS. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2000-12-28

2.  Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

Authors:  I Goldstein; T F Lue; H Padma-Nathan; R C Rosen; W D Steers; P A Wicker
Journal:  N Engl J Med       Date:  1998-05-14       Impact factor: 91.245

3.  Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group.

Authors:  H Padma-Nathan; W D Steers; P A Wicker
Journal:  Int J Clin Pract       Date:  1998-09       Impact factor: 2.503

Review 4.  The process of care model for evaluation and treatment of erectile dysfunction. The Process of Care Consensus Panel.

Authors: 
Journal:  Int J Impot Res       Date:  1999-04       Impact factor: 2.896

Review 5.  NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence.

Authors: 
Journal:  JAMA       Date:  1993-07-07       Impact factor: 56.272

6.  Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects.

Authors:  W W Dinsmore; M Hodges; C Hargreaves; I H Osterloh; M D Smith; R C Rosen
Journal:  Urology       Date:  1999-04       Impact factor: 2.649

7.  EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction.

Authors:  S E Althof; E W Corty; S B Levine; F Levine; A L Burnett; K McVary; V Stecher; A D Seftel
Journal:  Urology       Date:  1999-04       Impact factor: 2.649

8.  The role of the primary care clinician in the management of erectile dysfunction.

Authors:  Richard Sadovsky
Journal:  Rev Urol       Date:  2002

9.  Sildenafil citrate (VIAGRA) improves erectile function in elderly patients with erectile dysfunction: a subgroup analysis.

Authors:  G Wagner; F Montorsi; S Auerbach; M Collins
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-02       Impact factor: 6.053

10.  Indications and early results of sildenafil (Viagra) in erectile dysfunction.

Authors:  R Virag
Journal:  Urology       Date:  1999-12       Impact factor: 2.649

View more
  3 in total

Review 1.  Erectile Dysfunction: A Primer for in Office Management.

Authors:  Samir Sami; Noah Stern; Andrew Di Pierdomenico; Brandon Katz; Gerald Brock
Journal:  Med Sci (Basel)       Date:  2019-08-29

2.  Ginseng for erectile dysfunction.

Authors:  Hye Won Lee; Myeong Soo Lee; Tae-Hun Kim; Terje Alraek; Chris Zaslawski; Jong Wook Kim; Du Geon Moon
Journal:  Cochrane Database Syst Rev       Date:  2021-04-19

Review 3.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.